Get the Stockscreener App
10.31
3.19%
-0.34
After Hours:
10.31
Dynavax Technologies Corp stock is traded at $10.31, with a volume of 2.95M.
It is down -3.19% in the last 24 hours and down -24.36% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$10.65
Open:
$10.61
24h Volume:
2.95M
Relative Volume:
1.30
Market Cap:
$1.42B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
79.31
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-6.02%
1M Performance:
-24.36%
6M Performance:
-5.59%
1Y Performance:
-9.80%
1-Day Range:
$10.26
$10.79
1-Week Range:
$10.26
$11.47
52-Week Range:
$9.74
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
10.31 | 1.42B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
Where Dynavax Technologies Stands With Analysts - Benzinga
Dynavax And Deep Track Clash Over Board Seat Proposals - Finimize
Dynavax, Deep Track Capital Step Up Fight Ahead of June 11 Annual Meeting - MarketScreener
Deep Track Capital Comments on Dynavax Technologies? Rejection of Settlement Offer - MarketScreener
Dynavax (DVAX) Faces Shareholder Dispute as Deep Track Capital Pushes for Board Changes | DVAX Stock News - GuruFocus
Deep Track Dynavax Technologies' Board Rejects Nomination Of Four Candidates To Its Board - MarketScreener
Lobbying Update: $100,000 of DYNAVAX TECHNOLOGIES CORP. lobbying was just disclosed - Nasdaq
Raymond James Financial Inc. Purchases Shares of 15,047 Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Biodefense Market is Going to Boom | Major Giants Dynavax Technologies, Ichor Medical Systems - newstrail.com
PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose - TradingView
Dynavax Technologies (NASDAQ:DVAX) pulls back 6.5% this week, but still delivers shareholders strong 31% CAGR over 5 years - Yahoo Finance
Vanguard Group Inc. Has $116.95 Million Stake in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
17 Education & Technology Group (NYSE:YQ) vs. TCTM Kids IT Education (NASDAQ:TCTM) Head to Head Review - The AM Reporter
KLP Kapitalforvaltning AS Acquires Shares of 28,000 Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Dynavax reports strong performance ahead of shareholder meeting - Investing.com
Teacher Retirement System of Texas Acquires 3,797 Shares of Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Thrivent Financial for Lutherans Has $1.21 Million Stock Position in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Envestnet Portfolio Solutions Inc. Invests $131,000 in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High? - MSN
Dynavax Technologies Co. (NASDAQ:DVAX) Stock Holdings Lessened by Swiss National Bank - Defense World
Dynavax Technologies president sells $140,000 in stock By Investing.com - Investing.com Australia
Dynavax Technologies climbs as investor begins proxy fight (update) - MSN
Dynavax Technologies president sells $140,000 in stock - Investing.com India
Traders Purchase High Volume of Call Options on Dynavax Technologies (NASDAQ:DVAX) - Defense World
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Sold by PNC Financial Services Group Inc. - Defense World
Dynavax Technologies president sells $190,391 in stock By Investing.com - Investing.com Australia
Dynavax Technologies president sells $190,391 in stock - Investing.com
Why Dynavax Technologies (DVAX) Stock Might be a Great Pick - Yahoo Finance
Victory Capital Management Inc. Lowers Stock Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Dynavax Technologies Co. (NASDAQ:DVAX) Position Boosted by Bank of New York Mellon Corp - Defense World
Dynavax at Barclays Healthcare: Strategic Growth and Market Expansion - Investing.com
Dynavax technologies’ president & COO David Novack sells $471,473 in stock - Investing.com Canada
Dynavax Activist Investor Deep Track Capital Sends Letter to Company Board, Urging Director, Strategy Changes - Marketscreener.com
Deep Track Capital pushes for board changes at Dynavax By Investing.com - Investing.com Canada
Dynavax Turns Heads As HEPLISAV-B Shows Steady Growth In The Expanding Hepatitis B Vaccine Market - RTTNews
Deep Track Capital pushes for board changes at Dynavax - Investing.com
Major Dynavax Investor Pushes for Board Changes, Questions $265M Debt - StockTitan
Dynavax Technologies Corp. to Host Earnings Call - ACCESS Newswire
Dynavax at TD Cowen Conference: Strategic Growth and Future Plans - Investing.com
Dynavax Signs Debt Refinancing Deals, Plans $8 Million Stock Buyback -March 06, 2025 at 07:54 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing -March 06, 2025 at 07:28 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing, Common Stock Share Repurchase - Nasdaq
Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase - PR Newswire
Dynavax stock hits 52-week high at $14.05 amid robust growth - Investing.com Canada
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey
Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dynavax Technologies Corp Stock (DVAX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
0.74%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):